4 results
The objective of this project is to assess the applicability of [11C]GMOM for in vivo imaging of the NMDA receptor.
A potential reduction in pain could be obtained by the use of a thinner aspiration needle, 20 Gauge instead of 14 Gauge used right now. This is the reason for setting up a study that looks at the effect on pain perception in women by the use of a…
* To assess the safety and tolerability of Ampligen administered intranasally in a dosing schedule for 13 days (7 doses) in healthy subjects.* To characterize the mucosal immune response following Ampligen administration over time.
The primary objective of the safety run-in (phase Ib) is to determine the safety of combination therapy with durvalumab and rintatolimod. The primary objective of the phase II trial is to determine the clinical benefit rate of combination therapy…